Andrzej Witkowski
Research Subjects
Research Interests
Andrzej Witkowski has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Stuart Smith
14 shared publicationsAnil K. Joshi
5 shared publications- Giorgio Cavigiolio
Children's Hospital Oakland Research Institute, Oakland, CA, USA
3 shared publications - Robert O. Ryan
Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, United States
3 shared publications Anil K Joshi
2 shared publicationsAparna Krishnamoorthy
Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA 94720, USA
2 shared publications
Latest Publications
- 1 January 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 534, 261-265
trans-3-Methylglutaconyl CoA isomerization-dependent protein acylation
- 1 January 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 534, 261-265
trans-3-Methylglutaconyl CoA isomerization-dependent protein acylation
- Open Access
- 1 March 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (10) , 3634-3646
Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule
- 1 March 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (10) , 3634-3646
Open AccessOxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule
- Open Access
- 17 January 2018
- Published by Wiley in The FASEB Journal
- Vol. 32 (6) , 3149-3165
Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation
Apolipoprotein A‐I (apoA‐I) shares with other exchangeable apolipoproteins a high level of structural plasticity. In the lipid‐free state, the apolipoprotein amphipathic a‐helices interact intra‐ and intermolecularly, providing structural stabilization by self‐association. We have reported that lipid‐free apoA‐I becomes amyloidogenic upon physiologically relevant (myeloperoxidase‐mediated) Met oxidation. In this study, we established that Met oxidation promotes amyloidogenesis by reducing the stability of apoA‐I monomers and irreversibly disrupting selfassociation. The oxidized apoA‐I monomers also exhibited increased cellular cholesterol release capacity and stronger association with macrophages, compared to nonoxidized apoA‐I. Of physiologic relevance, preformed oxidized apoA‐I amyloid fibrils induced amyloid formation in nonoxidized apoA‐I. This process was enhanced when self‐association of nonoxidized apoA‐I was disrupted by thermal treatment. Solid state NMR analysis revealed that aggregates formed by seeded nonoxidized apoA‐I were structurally similar to those formed by the oxidized protein, featuring a β‐structure‐rich amyloid fold alongside a‐helices retained from the native state. In atherosclerotic lesions, the conditions that promote apoA‐I amyloid formation are readily available: myeloperoxidase, active oxygen species, low pH, and high concentration of lipid‐free apoA‐I. Our results suggest that even partial Met oxidation of apoA‐I can nucleate amyloidogenesis, thus sequestering and inactivating otherwise antiatherogenic and HDL‐forming apoA‐I.—Witkowski, A., Chan, G. K. L., Boatz, J. C., Li, N. J., Inoue, A. P., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation. FASEB J. 32, 3149–3165 (2018). www.fasebj.org
- 17 January 2018
- Published by Wiley in The FASEB Journal
- Vol. 32 (6) , 3149-3165
Open AccessMethionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation
Apolipoprotein A‐I (apoA‐I) shares with other exchangeable apolipoproteins a high level of structural plasticity. In the lipid‐free state, the apolipoprotein amphipathic a‐helices interact intra‐ and intermolecularly, providing structural stabilization by self‐association. We have reported that lipid‐free apoA‐I becomes amyloidogenic upon physiologically relevant (myeloperoxidase‐mediated) Met oxidation. In this study, we established that Met oxidation promotes amyloidogenesis by reducing the stability of apoA‐I monomers and irreversibly disrupting selfassociation. The oxidized apoA‐I monomers also exhibited increased cellular cholesterol release capacity and stronger association with macrophages, compared to nonoxidized apoA‐I. Of physiologic relevance, preformed oxidized apoA‐I amyloid fibrils induced amyloid formation in nonoxidized apoA‐I. This process was enhanced when self‐association of nonoxidized apoA‐I was disrupted by thermal treatment. Solid state NMR analysis revealed that aggregates formed by seeded nonoxidized apoA‐I were structurally similar to those formed by the oxidized protein, featuring a β‐structure‐rich amyloid fold alongside a‐helices retained from the native state. In atherosclerotic lesions, the conditions that promote apoA‐I amyloid formation are readily available: myeloperoxidase, active oxygen species, low pH, and high concentration of lipid‐free apoA‐I. Our results suggest that even partial Met oxidation of apoA‐I can nucleate amyloidogenesis, thus sequestering and inactivating otherwise antiatherogenic and HDL‐forming apoA‐I.—Witkowski, A., Chan, G. K. L., Boatz, J. C., Li, N. J., Inoue, A. P., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation. FASEB J. 32, 3149–3165 (2018). www.fasebj.org
- 16 January 2018
- Published by Springer Nature in Investigational New Drugs
- Vol. 36 (5) , 743-754
Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway
Neuroblastoma is a childhood malignancy that accounts for approximately 15% of childhood cancer deaths. Only 20–35% of children with metastatic neuroblastoma survive with standard therapy. Identification of more effective therapies is essential to improving the outcome of children with high-stage disease. Sphingadienes (SD) are growth-inhibitory sphingolipids found in natural sources including soy. They exhibit chemopreventive activity in mouse models of colon cancer, where they mediate cytotoxicity by inhibiting key pro-carcinogenic signaling pathways. In this study, the effect of SD on neuroblastoma was analyzed. Low micromolar concentrations of SD were cytotoxic to transformed and primary neuroblastoma cells independently of N-Myc amplification status. SD induced both caspase-dependent apoptosis and autophagy in neuroblastoma cells. However, only inhibition of caspase-dependent apoptosis protected neuroblastoma cells from SD-mediated cytotoxicity. SD also inhibited AKT activation in neuroblastoma cells as shown by reduced phosphorylated AKT levels. Pre-treatment with insulin attenuated SD-mediated cytotoxicity in vitro. SD-loaded nanoparticles (NP) administered parenterally to immunodeficient mice carrying neuroblastoma xenografts resulted in cytotoxic levels of SD in the circulation and significantly reduced tumor growth compared to vehicle-treated controls. Analysis of tumor extracts demonstrated reduced AKT activation in tumors of mice treated with SD-NP compared to controls treated with empty NP. Our findings indicate SD are novel potential chemotherapeutic agents that promote neuroblastoma cell death and reduce tumorigenicity in vivo.
- 16 January 2018
- Published by Springer Nature in Investigational New Drugs
- Vol. 36 (5) , 743-754
Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway
Neuroblastoma is a childhood malignancy that accounts for approximately 15% of childhood cancer deaths. Only 20–35% of children with metastatic neuroblastoma survive with standard therapy. Identification of more effective therapies is essential to improving the outcome of children with high-stage disease. Sphingadienes (SD) are growth-inhibitory sphingolipids found in natural sources including soy. They exhibit chemopreventive activity in mouse models of colon cancer, where they mediate cytotoxicity by inhibiting key pro-carcinogenic signaling pathways. In this study, the effect of SD on neuroblastoma was analyzed. Low micromolar concentrations of SD were cytotoxic to transformed and primary neuroblastoma cells independently of N-Myc amplification status. SD induced both caspase-dependent apoptosis and autophagy in neuroblastoma cells. However, only inhibition of caspase-dependent apoptosis protected neuroblastoma cells from SD-mediated cytotoxicity. SD also inhibited AKT activation in neuroblastoma cells as shown by reduced phosphorylated AKT levels. Pre-treatment with insulin attenuated SD-mediated cytotoxicity in vitro. SD-loaded nanoparticles (NP) administered parenterally to immunodeficient mice carrying neuroblastoma xenografts resulted in cytotoxic levels of SD in the circulation and significantly reduced tumor growth compared to vehicle-treated controls. Analysis of tumor extracts demonstrated reduced AKT activation in tumors of mice treated with SD-NP compared to controls treated with empty NP. Our findings indicate SD are novel potential chemotherapeutic agents that promote neuroblastoma cell death and reduce tumorigenicity in vivo.
- 1 September 2017
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 630, 38-46
Characterization of secondary structure and lipid binding behavior of N-terminal saposin like subdomain of human Wnt3a
- 1 September 2017
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 630, 38-46
Characterization of secondary structure and lipid binding behavior of N-terminal saposin like subdomain of human Wnt3a
- Open Access
- 23 August 2016
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 14 (1) , 66
Wnt3a nanodisks promote ex vivo expansion of hematopoietic stem and progenitor cells
Wnt proteins modulate development, stem cell fate and cancer through interactions with cell surface receptors. Wnts are cysteine-rich, glycosylated, lipid modified, two domain proteins that are prone to aggregation. The culprit responsible for this behavior is a covalently bound palmitoleoyl moiety in the N-terminal domain. By combining murine Wnt3a with phospholipid and apolipoprotein A-I, ternary complexes termed nanodisks (ND) were generated. ND-associated Wnt3a is soluble in the absence of detergent micelles and gel filtration chromatography revealed that Wnt3a co-elutes with ND. In signaling assays, Wnt3a ND induced β-catenin stabilization in mouse fibroblasts as well as hematopoietic stem and progenitor cells (HSPC). Prolonged exposure of HSPC to Wnt3a ND stimulated proliferation and expansion of Lin− Sca-1+ c-Kit+ cells. Surprisingly, ND lacking Wnt3a contributed to Lin− Sca-1+ c-Kit+ cell expansion, an effect that was not mediated through β-catenin. The data indicate Wnt3a ND constitute a water-soluble transport vehicle capable of promoting ex vivo expansion of HSPC.
- 23 August 2016
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 14 (1) , 66
Open AccessWnt3a nanodisks promote ex vivo expansion of hematopoietic stem and progenitor cells
Wnt proteins modulate development, stem cell fate and cancer through interactions with cell surface receptors. Wnts are cysteine-rich, glycosylated, lipid modified, two domain proteins that are prone to aggregation. The culprit responsible for this behavior is a covalently bound palmitoleoyl moiety in the N-terminal domain. By combining murine Wnt3a with phospholipid and apolipoprotein A-I, ternary complexes termed nanodisks (ND) were generated. ND-associated Wnt3a is soluble in the absence of detergent micelles and gel filtration chromatography revealed that Wnt3a co-elutes with ND. In signaling assays, Wnt3a ND induced β-catenin stabilization in mouse fibroblasts as well as hematopoietic stem and progenitor cells (HSPC). Prolonged exposure of HSPC to Wnt3a ND stimulated proliferation and expansion of Lin− Sca-1+ c-Kit+ cells. Surprisingly, ND lacking Wnt3a contributed to Lin− Sca-1+ c-Kit+ cell expansion, an effect that was not mediated through β-catenin. The data indicate Wnt3a ND constitute a water-soluble transport vehicle capable of promoting ex vivo expansion of HSPC.
- Open Access
- 1 April 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (17) , 10958-10971
Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I
- 1 April 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (17) , 10958-10971
Open AccessMyeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I
- 1 February 2015
- Published by Elsevier in Protein Expression and Purification
- Vol. 106, 41-48
Isolation and characterization of recombinant murine Wnt3a
- 1 February 2015
- Published by Elsevier in Protein Expression and Purification
- Vol. 106, 41-48
Isolation and characterization of recombinant murine Wnt3a
- 1 October 2014
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 34 (10) , 2254-2260
Aberrant Hetero-Disulfide Bond Formation by the Hypertriglyceridemia-Associated p.Gly185Cys APOA5 Variant (rs2075291)
Objective—: Apolipoprotein A-V (apoA-V) is a low-abundance plasma protein that modulates triacylglycerol homeostasis. Gene transfer studies were undertaken in apoa5 (−/−) mice to define the mechanism underlying the correlation between the single-nucleotide polymorphism c.553G>T in APOA5 and hypertriglyceridemia. Approach and Results—: Adeno-associated virus (AAV) 2/8–mediated gene transfer of wild-type apoA-V induced a dramatic lowering of plasma triacylglycerol in apoa5 (−/−) mice, whereas AAV2/8-Gly162Cys apoA-V (corresponding to the c.553G>T single-nucleotide polymorphism: rs2075291; p.Gly185Cys when numbering includes signal sequence) had a modest effect. Characterization studies revealed that plasma levels of wild-type and G162C apoA-V in transduced mice were similar and within the physiological range. Fractionation of plasma from mice transduced with AAV2/8-G162C apoA-V indicated that, unlike wild-type apoA-V, >50% of G162C apoA-V was recovered in the lipoprotein-free fraction. Nonreducing SDS-PAGE immunoblot analysis provided evidence that G162C apoA-V present in the lipoprotein-free fraction, but not that portion associated with lipoproteins, displayed altered electrophoretic mobility consistent with disulfide-linked heterodimer formation. Immunoprecipitation followed by liquid chromatography/mass spectrometry of human plasma from subjects homozygous for wild-type APOA5 and c.553G>T APOA5 revealed that G162C apoA-V forms adducts with extraneous plasma proteins including fibronectin, kininogen-1, and others. Conclusions—: Substitution of Cys for Gly at position 162 of mature apoA-V introduces a free cysteine that forms disulfide bonds with plasma proteins such that its lipoprotein-binding and triacylglycerol-modulation functions are compromised.
- 1 October 2014
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 34 (10) , 2254-2260
Aberrant Hetero-Disulfide Bond Formation by the Hypertriglyceridemia-Associated p.Gly185Cys APOA5 Variant (rs2075291)
Objective—: Apolipoprotein A-V (apoA-V) is a low-abundance plasma protein that modulates triacylglycerol homeostasis. Gene transfer studies were undertaken in apoa5 (−/−) mice to define the mechanism underlying the correlation between the single-nucleotide polymorphism c.553G>T in APOA5 and hypertriglyceridemia. Approach and Results—: Adeno-associated virus (AAV) 2/8–mediated gene transfer of wild-type apoA-V induced a dramatic lowering of plasma triacylglycerol in apoa5 (−/−) mice, whereas AAV2/8-Gly162Cys apoA-V (corresponding to the c.553G>T single-nucleotide polymorphism: rs2075291; p.Gly185Cys when numbering includes signal sequence) had a modest effect. Characterization studies revealed that plasma levels of wild-type and G162C apoA-V in transduced mice were similar and within the physiological range. Fractionation of plasma from mice transduced with AAV2/8-G162C apoA-V indicated that, unlike wild-type apoA-V, >50% of G162C apoA-V was recovered in the lipoprotein-free fraction. Nonreducing SDS-PAGE immunoblot analysis provided evidence that G162C apoA-V present in the lipoprotein-free fraction, but not that portion associated with lipoproteins, displayed altered electrophoretic mobility consistent with disulfide-linked heterodimer formation. Immunoprecipitation followed by liquid chromatography/mass spectrometry of human plasma from subjects homozygous for wild-type APOA5 and c.553G>T APOA5 revealed that G162C apoA-V forms adducts with extraneous plasma proteins including fibronectin, kininogen-1, and others. Conclusions—: Substitution of Cys for Gly at position 162 of mature apoA-V introduces a free cysteine that forms disulfide bonds with plasma proteins such that its lipoprotein-binding and triacylglycerol-modulation functions are compromised.